Eli Lilly's Foundayo Pricing Strategy

FDA approved Eli Lilly's GLP-1 pill Foundayo.
Foundayo launched via LillyDirect for direct-to-consumer access.
Competes with Novo Nordisk's Wegovy in GLP-1 market.
Insurance patients pay $25/month; out-of-pocket costs $149–$349.
Medicare seniors pay $50/month starting summer.
Lilly invested $55B since 2020 for global rollout.

Pricing | Competition | Drug Approval

United States | India | Over 40 countries

Kansal

3 hours ago